Interlaboratory variation in PD-L1 positivity in non-small cell lung cancer patients: a comparison between histological and cytological material

被引：0
|
作者：
Koomen, B. [1 ]
Voorham, R. [2 ]
Kuijpers, C. [1 ]
Deckers, I. [2 ]
Willems, S. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[2] PALGA Fdn Nationwide Network & Registry Histo & C, Houten, Netherlands
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-10-004
引用
收藏
页码：S39 / S40
页数：2
相关论文
共 50 条
  • [41] Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer
    Montero, M. Angeles
    Aricak, Ozan
    Kis, Lorand
    Yoshikawa, Akira
    De Petris, Luigi
    Grundberg, Oscar
    Pham, Hoa H. N.
    Roden, Anja C.
    Fukuoka, Junya
    Attanoos, Richard
    Guijarro, Ricardo
    Alarcon, Felix
    Lindstrom, Kati
    Ortiz-Villalon, Cristian
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2021, 51
  • [42] Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer.
    Rizvi, Hira
    Bandlamudi, Chaitanya
    Schoenfeld, Adam Jacob
    Sauter, Jennifer L.
    Arbour, Kathryn Cecilia
    Beras, Amanda
    Egger, Jacklynn V.
    Ladanyi, Marc
    Donoghue, Mark
    Rudin, Charles M.
    Taylor, Barry S.
    Hellmann, Matthew David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] PD-L1 and molecular biomarker expression in non-small cell lung cancer in Tunisian patients
    Houcine, Yoldez
    Moussa, Chirine
    Ben Abdelaziz, Ahmed
    Ayadi, Aida
    MONALDI ARCHIVES FOR CHEST DISEASE, 2024, 94 (04)
  • [44] PD-L1 expression is associated with advanced non-small cell lung cancer
    Chen, Zhiquan
    Mei, Jiandong
    Liu, Lunxu
    Wang, Guochen
    Li, Zuosheng
    Hou, Jingpu
    Zhang, Qiuyang
    You, Zongbing
    Zhang, Liu
    ONCOLOGY LETTERS, 2016, 12 (02) : 921 - 927
  • [45] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430
  • [46] PD-L1 Immunohistochemistry for Non-Small Cell Lung Cancer on Cytology Specimens
    Banach, Bridget
    Antic, Tatjana
    Mueller, Jeffrey
    LABORATORY INVESTIGATION, 2018, 98 : 133 - 133
  • [47] Challenges of PD-L1 testing in non-small cell lung cancer and beyond
    Wang, Minyu
    Wang, Sen
    Trapani, Joseph A.
    Neeson, Paul J.
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4541 - 4548
  • [48] COMPARISON OF PD-L1 EXPRESSION BETWEEN PREOPERATIVE BIOPSY SPECIMENS AND SURGICAL SPECIMENS IN NON-SMALL CELL LUNG CANCER
    Sakaguchi, Tadashi
    Itou, Kentarou
    Hataji, Osamu
    CHEST, 2024, 166 (04) : 4392A - 4392A
  • [49] The Percentage of PD-L1 Besides 50% Positivity Predicts Objective Response to Pembrolizumab in Non-Small Cell Lung Cancer
    Poma, A.
    Pasquini, G.
    Bruno, R.
    Ali, G.
    Proietti, A.
    Pecora, I.
    Petrini, L.
    Vasile, E.
    Chella, A.
    Fontanini, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S466 - S467
  • [50] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345